| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/21/2009 | CN101347549A Medicament composition for treating intumescence and infection contamination of navel section of newborn infant as well as preparation method thereof |
| 01/21/2009 | CN101347543A Chinese medicine compound and preparation method thereof |
| 01/21/2009 | CN101347523A Microsphere for injuecting 'Shuang Hualian' for treating viral disease of bird and preparation thereof |
| 01/21/2009 | CN101347522A Nano 'Shuang Hualian' injection preparation for fowl and preparation thereof |
| 01/21/2009 | CN101347516A Method for preparing total free anthraquinones extract from rhubarb |
| 01/21/2009 | CN101347512A Macleaya cordata injection and preparation thereof |
| 01/21/2009 | CN101347499A Chinese medicine external-use medical ointment for treating innominate inflammatory and acariasis |
| 01/21/2009 | CN101347492A Use of Trigonostemon xyphophylloides extract in preparing anti-AIDS medicament |
| 01/21/2009 | CN101347432A Long-acting enrofloxacin injection for livestock and poultry and method of preparing the same |
| 01/21/2009 | CN101347430A Pseudoephedrine hydrochloride oral administration solution and method of preparing the same |
| 01/21/2009 | CN101347420A Alficetin soft capsules |
| 01/21/2009 | CN101347416A Capsules type acetaminopher drop and method of preparing the same |
| 01/21/2009 | CN101347407A Cefquinome sulfate injection and process for producing the same |
| 01/21/2009 | CN101347237A Cold tea beverage preparation for transforming viral hepatitis í«great three positiveí» into negative |
| 01/21/2009 | CN100453643C Purification method of human glutathione-s-transferase Pi and application of said enzyme |
| 01/21/2009 | CN100453553C Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/21/2009 | CN100453547C Inhibitors |
| 01/21/2009 | CN100453104C Natural botanical extraction liquid for preventing and treating epidemic febrile disease of birds and livestock and method for preparing same |
| 01/21/2009 | CN100453087C Medicine for treating tuberculosis |
| 01/21/2009 | CN100453072C Isatis root drops and preparation thereof |
| 01/21/2009 | CN100453068C Injection containing caderfloxacin lactate |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479503 Such as multiple sclerosis; also inactivating HIV virus via extracorporeal treatment of blood; use of a green porphyrin or porfimer sodium |
| 01/20/2009 | US7479497 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479285 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 01/20/2009 | US7479283 Synergistic; LPF, a sub-unit protein vaccine based on pertussis toxin, is not required |
| 01/20/2009 | US7479282 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | CA2567575C Organo-gel formulations for therapeutic applications |
| 01/20/2009 | CA2528493C Medicinal composition containing triazole compound |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2444116C Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 01/20/2009 | CA2393518C Amycomycin, a process for its production and its use as a pharmaceutical |
| 01/20/2009 | CA2376676C Respiratory syncytial virus replication inhibitors |
| 01/20/2009 | CA2352762C Oral transmucosal delivery |
| 01/20/2009 | CA2352389C An oral formulation for gastrointestinal drug delivery |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2327495C Form vi 5,6-dichloro-2-(isopropylamino)-1-(.beta.-l-ribofuranosyl)-1h-benzimidazole |
| 01/20/2009 | CA2296018C Inhibition of hiv-1 replication using oligocarbamate derivatives |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/17/2009 | CA2631685A1 Hair conditioning composition containing a non-guar galactomannan polymer derivative |
| 01/15/2009 | WO2009009727A2 Ghrh analogs and therapeutic uses thereof |
| 01/15/2009 | WO2009009531A2 Pyrimidinecarboxamide derivatives for the treatment of hiv infections |
| 01/15/2009 | WO2009009365A1 Compositions and methods for preventing or treating disease caused by polyomavirus infection or reactivation in a mammalian subject |
| 01/15/2009 | WO2009009171A2 Methods for preventing or treating infectious diseases using gallium compounds |
| 01/15/2009 | WO2009009115A2 Liposome compositions for treatment of hepatitis c |
| 01/15/2009 | WO2009009001A1 Crystalline pyridazine compound |
| 01/15/2009 | WO2009008989A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/15/2009 | WO2009008913A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/15/2009 | WO2009008905A1 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 01/15/2009 | WO2009008569A1 Production methods of green tea extracts for preventing adhesion of pathogenic bacteria to human cell |
| 01/15/2009 | WO2009008362A1 Method for producing composition containing sialic acid compound |
| 01/15/2009 | WO2009007982A1 A conserved region of the hiv-1 genome and uses thereof |
| 01/15/2009 | WO2009007441A2 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 01/15/2009 | WO2009006701A1 Topical medicament |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018213 Antiviral method |
| 01/15/2009 | US20090018169 Sulfonamide Derivatives for the Treatment of Bacterial Infections |
| 01/15/2009 | US20090018162 Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 01/15/2009 | US20090018155 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy |
| 01/15/2009 | US20090018149 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018126 pyrimidine- or pyridinecarboxylic acid derivatives which are substituted in the 2- or 4-position by an optionally substituted 4-(3-oxomorpholin-4-yl)aniline radical, such as 6-methyl-2-[4-(3-oxomorpholin-4-yl)phenylamino]nicotinic acid, suitable for the treatment of viral diseases, such as hepatitis C |
| 01/15/2009 | US20090018123 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018111 Novel Antimicrobial Medicament |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018091 Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
| 01/15/2009 | US20090018090 Process for preparation of anhydrous azithromycin |
| 01/15/2009 | US20090018086 Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus |
| 01/15/2009 | US20090018079 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017132 Disinfectant cleaning composition and method |
| 01/15/2009 | US20090017108 Liposome compositions for treatment of hepatitis C |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| 01/15/2009 | US20090017072 Pneumococcal capsular saccharides complex vaccine; for infants |
| 01/15/2009 | US20090017068 Vaccines against West Nile Virus |
| 01/15/2009 | US20090017066 Novel vlps derived from cells that do not express a viral matrix or core protein |
| 01/15/2009 | US20090017064 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 01/15/2009 | US20090017063 Edible vaccine |
| 01/15/2009 | US20090017062 Using variation in NADPH oxidase activity as evaluative tool in identifying modulators which enhance parvovirus transduction |
| 01/15/2009 | US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/15/2009 | US20090017053 Composition and Method for Preventing or Treating a Virus Infection |
| 01/15/2009 | US20090017052 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017046 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 01/15/2009 | US20090017044 Antibodies to the Human Prolactin Receptor |
| 01/15/2009 | US20090017027 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 01/15/2009 | US20090017026 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |